A Study of Nighttime Blood Sugar Control Patterns in Type 2 Diabetes
Overview
Tab Title Description
Study type
ObservationalDescribes the nature of a clinical study. Types include:
- Observational study — observes people and measures outcomes without affecting results.
- Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
- Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
Study IDs
Site IRB
- Rochester, Minnesota: 13-009661
Sponsor Protocol Number: 13-009661
About this study
The purpose of this study is to understand nighttime glucose regulation in humans and find if the pattern is different in people with Type 2 diabetes
Participation eligibility
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.
Inclusion Criteria
- 30 subjects per group and may need to screen up to 120
- 30-75 years of age
- body mass index (BMI) of 27-40 kg/m2
- Groups will be matched for age, sex and BMI
- The ADA criteria for fasting glucose will be applied
- Type 2 Diabetes subjects on lifestyle treatment, with or without combination therapy with metformin and sulphonylurea will have an HbA1c of ≤ 10.%
Exclusion Criteria
- Diabetics on insulin, glucagon-like peptide-1 based therapies or thiazolidinediones
- Type 2 Diabetic subjects with microvascular or macrovascular complications (apart from mild background retinopathy)
- any forms of sleep disorder identified during the screening process.
Participating Mayo Clinic locations
Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.
| Mayo Clinic Location |
Status |
|
Rochester, Minn.
Mayo Clinic principal investigator Kelly Dunagan, R.N. |
Closed for enrollment |
|
More information
Publications
Publications are currently not available